Clinical and Translational Science Center (KL2)

对未来的研究人员进行临床和翻译(C/T)研究的科学和伦理方面的严格培训 对于解决预期的合格临床研究人员短缺、增加成功几率至关重要 并最终影响临床护理的质量。众所周知，重大进展将继续出现。 来自科学家，他们受到以疾病为导向的研究的智力挑战的激励 新的生物发现。循证医学依赖于临床的结果和解释 调查。因此，必须对临床和翻译研究人员进行适当的培训，以便 他们的研究不受错误结论、浪费资源或临床试验设计缺陷的影响， 数据的分析和解释。 为此，良好协调和整合的临床和转译研究培训努力 利用不同的跨机构教员和其他资源进行教学和辅导。 教员来自威尔康奈尔医学和研究生院，纪念斯隆·凯特林 癌症中心、特殊外科医院、亨特学院护理学院、亨特学院基因 中心(少数民族机构研究中心)和广泛的社区外展方案协调 通过康奈尔大学合作扩展-纽约市。 如本章各章所述和本章第十六节所概述的， 学员可以使用许多最先进的设施、扩大的临床研究中心(PCIR)、技术 和支持核心设施，以及来自其合作医院的大量和多样化的患者群体(见部分 XVI)。

Rigorous training of future investigators in the science and ethics of clinical and translational (C/T) research is essential to address the anticipated shortage of qualified clinical researchers, increase the odds of success and ultimately impact the quality of clinical care. It is well known that major advances will continue to come from scientists who are motivated by the intellectual challenges of disease-oriented research in their search for new biological discoveries. Evidence-based medicine depends on the results and interpretation of clinical investigations. It is Imperative, therefore, that clinical and translational researchers are properly trained so that their research does not suffer from erroneous conclusions, wasted resources or flaws in clinical trial design, analysis and interpretation of data. To this end, a well-coordinated and integrated clinical and translational research training endeavor has been developed utilizing the diverse trans-institutional faculty and other resources for teaching and mentoring. The members of the faculty are from Weill Cornell Medical and Graduate Schools, Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, the Hunter College School of Nursing, the Hunter College Gene Center (Research Center for Minority Institutions) and the extensive community outreach program coordinated through the Cornell University Cooperative Extension-NYC. As described in the various chapters of this grant and summarized in section XVI of this chapter, the trainees have access to many state-of-the-art facilities, an expanded clinical research center (PCIR), technical and support core facilities, and a large and diverse patient population from its partner hospitals, (see section XVI).